ACB Stock Overview
Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Aurora Cannabis Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$7.20 |
| 52 Week High | CA$11.50 |
| 52 Week Low | CA$2.84 |
| Beta | 2.93 |
| 1 Month Change | 73.91% |
| 3 Month Change | 77.78% |
| 1 Year Change | 26.29% |
| 3 Year Change | -92.04% |
| 5 Year Change | -99.33% |
| Change since IPO | -80.83% |
Recent News & Updates
Recent updates
Aurora launches new cannabis products for adult and medical-use
Oct 17Aurora Cannabis further strengthens its balance sheet by repurchasing ~US$23M of convertible notes
Oct 07Aurora Cannabis Q4 2022 Earnings Preview
Sep 19Aurora Cannabis: Don't Let Your Money Go Up In Smoke
Aug 25Why Did Aurora Cannabis Stock Crash In May; Can It Recover?
Jun 13Recent Developments Do Not Change Our Stance On Aurora Cannabis
May 13Aurora Cannabis: A Train Wreck Desperate For Help
May 05Aurora Cannabis: The Fallen Pot Giant That Still Can't Find Its Way
Feb 17Aurora Cannabis Vs. HEXO: Which Is The Better Cannabis Stock?
Dec 17Tilray Vs. Aurora Cannabis: How To Compare These Cannabis Stocks
Oct 11Aurora Cannabis: Investors Should Have No Confidence In This Company
Sep 28Is Aurora Cannabis Stock A Buy Or Sell Before Upcoming Earnings? Buy The U.S. Opportunity
Sep 16Aurora Cannabis Is A Pass For Now, Although We Are Bullish On The Industry
Jun 05Aurora Cannabis: Extreme Downside Case Averted
Feb 02Aurora Cannabis inks exclusive representative agreement with Great North Distributors
Jan 14How To Recoup Your Losses In Aurora Cannabis
Dec 24Aurora downgraded by BMO citing ‘out-of-line’ valuation
Dec 18Aurora to lay off 200 employees, idles substantial part of flagship Sky marijuana facility
Dec 16It's Not Just Aurora, Bearish On All Cannabis Stocks
Dec 08U.S. House gears up for historic vote on cannabis legalization
Dec 04Aurora Cannabis (ACB) Investor Presentation - Slideshow
Dec 02Aurora Cannabis inks supply deal for bulk dried flower with Cantek, shares down 6%
Nov 25Pot stocks rally as Trump administration proceeds with transition to Biden
Nov 24Aurora Cannabis: Too Many Questions Still Exist
Nov 10Shareholder Returns
| ACB | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 24.4% | 0.9% | 1.2% |
| 1Y | 26.3% | 13.9% | 24.7% |
Return vs Industry: ACB exceeded the US Pharmaceuticals industry which returned 13.9% over the past year.
Return vs Market: ACB exceeded the US Market which returned 24.7% over the past year.
Price Volatility
| ACB volatility | |
|---|---|
| ACB Average Weekly Movement | 20.0% |
| Pharmaceuticals Industry Average Movement | 9.9% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: ACB's share price has been volatile over the past 3 months.
Volatility Over Time: ACB's weekly volatility (20%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 1,130 | Miguel Martin | www.auroramj.com |
Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Aurora Cannabis Inc. Fundamentals Summary
| ACB fundamental statistics | |
|---|---|
| Market cap | US$401.66m |
| Earnings (TTM) | US$299.78m |
| Revenue (TTM) | US$201.36m |
1.3x
P/E Ratio1.9x
P/S RatioIs ACB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ACB income statement (TTM) | |
|---|---|
| Revenue | CA$275.88m |
| Cost of Revenue | CA$190.60m |
| Gross Profit | CA$85.29m |
| Other Expenses | -CA$325.43m |
| Earnings | CA$410.72m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 7.53 |
| Gross Margin | 30.91% |
| Net Profit Margin | 148.87% |
| Debt/Equity Ratio | 9.8% |
How did ACB perform over the long term?
See historical performance and comparison